Effect of recombinant human erythropoietin and doxorubicin in combination on the proliferation of MCF-7 and MDA-mb231 breast cancer cells
Patients with cancer often exhibit signs of anemia as the result of the disease. Thus, cancer chemotherapies often include erythropoietin (EPO) in the regime to improve the survival rate of these patients. The aim of the present study was to determine the effect of EPO on doxorubicin-treated breast...
Main Authors: | , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Spandidos Publications
2016
|
Subjects: | |
Online Access: | http://psasir.upm.edu.my/id/eprint/54047/1/Effect%20of%20recombinant%20human%20erythropoietin%20and%20doxorubicin.pdf |